Hologic, Inc. Stock
Stocks
HOLX
US4364401012
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 07-01 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| 05-26 | Hologic and Biotheranostics Present New Data on Breast Cancer Index Test At Asco 2026 | CI |
| Market Cap | 16.97B 14.89B 13.87B 12.75B 23.91B 1,621B 24.32B 165B 64.4B 804B 63.7B 62.33B 2,778B | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39B 15.26B 14.21B 13.07B 24.5B 1,661B 24.92B 169B 65.99B 824B 65.28B 63.87B 2,847B | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +1.21% | ||
| Current year | +2.04% |
| Current year | 74.49 |  | 76.07 |
| 1 year | 63.19 | | 76.07 |
| 3 years | 51.9 | | 84.67 |
| 5 years | 51.9 | | 87.88 |
| 10 years | 26.49 | | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 07/04/2026 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 16/04/2026 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 07/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/4/26 | Issuer sale | Chief Operating Officer | 242,362 | 0.1086% | ||
| 7/4/26 | Issuer sale | Director | 56,632 | 0.0254% | ||
| 7/4/26 | Issuer sale | Executive/Senior Manager | 123,246 | 0.0552% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | -.--% | +15.71% | -5.80% | 16.97B | |
| +3.02% | +10.12% | +18.86% | +2.59% | 208B | |
| +1.30% | +11.19% | -1.92% | -23.46% | 138B | |
| +1.39% | +3.35% | -26.75% | +10.80% | 126B | |
| +1.21% | +6.65% | -56.48% | -10.89% | 67.64B | |
| +0.77% | -1.03% | +6.61% | -0.07% | 47.81B | |
| +1.01% | +4.09% | -24.96% | -31.74% | 45.03B | |
| +1.92% | +5.78% | +17.57% | +11.50% | 38.94B | |
| +3.42% | +4.45% | +26.97% | +34.34% | 36.45B | |
| +2.90% | +6.72% | -23.60% | -6.37% | 29.29B | |
| Average | +1.74% | +4.12% | -4.80% | -1.91% | 75.43B | |
| Weighted average by Cap. | +1.91% | +5.18% | -4.11% | -2.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.03B 3.54B 3.29B 3.03B 5.68B 385B 5.78B 39.08B 15.29B 191B 15.13B 14.8B 660B | 4.1B 3.6B 3.35B 3.08B 5.78B 392B 5.88B 39.76B 15.56B 194B 15.39B 15.06B 671B |
| Net income | 790M 693M 645M 593M 1.11B 75.43B 1.13B 7.65B 3B 37.41B 2.96B 2.9B 129B | 566M 496M 462M 425M 797M 54.04B 811M 5.48B 2.15B 26.8B 2.12B 2.08B 92.6B |
| Net Debt | 321M 282M 263M 242M 453M 30.7B 460M 3.12B 1.22B 15.22B 1.21B 1.18B 52.6B | 421M 369M 344M 316M 593M 40.21B 603M 4.08B 1.6B 19.94B 1.58B 1.55B 68.9B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
